The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Lenus Finvest Pvt Ltd
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Lenus Finvest Private Limited, part of the promoter group of Eiko Lifesciences Ltd, bought 7,444 equity shares (0.05% of total) through open market purchases on 2-3 September 2025. After this acquisition, Lenus Finvest's holding increased from 23,58,028 shares (17.19%) to 23,65,472 shares (17.24%) of the company. The disclosure was filed under Regulation 29(2) of SEBI Takeover Regulations. Total equity share capital of Eiko Lifesciences remains 1,37,20,854 shares of Rs. 10 each.
This is a minor incremental purchase by a promoter group entity, signalling continued promoter confidence but having negligible impact on shareholding pattern or stock price.